Saudi guidelines on the diagnosis and treatment of pulmonary hypertension: Pulmonary arterial hypertension associated with congenital heart disease

Annals of Thoracic Medicine

Volumn 9, Issue SUPPL. 1, 2014, Pages

  Lopes, Antonio ^a   Alnajashi, Khalid ^b  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b PRINCE SULTAN CARDIAC CENTER   (Saudi Arabia)

Author keywords

congenital heart disease; Pulmonary arterial hypertension; saudi association for pulmonary hypertension guidelines

Indexed keywords

ANTIARRHYTHMIC AGENT; ANTICOAGULANT AGENT; NITRIC OXIDE; VASODILATOR AGENT; WARFARIN;

ANTICOAGULATION; ARTICLE; ATRIOVENTRICULAR SEPTAL DEFECT; CARDIOVASCULAR SURGERY; CONGENITAL HEART DISEASE; CONSENSUS DEVELOPMENT; DISEASE ASSOCIATION; DISEASE COURSE; DOWN SYNDROME; HEART ARRHYTHMIA; HEART CATHETERIZATION; HEART LUNG TRANSPLANTATION; HEART VENTRICLE SEPTUM DEFECT; HUMAN; IMPLANTABLE CARDIOVERTER DEFIBRILLATOR; LIFE EXPECTANCY; OXYGEN SATURATION; OXYGEN THERAPY; PATENT DUCTUS ARTERIOSUS; PATIENT COUNSELING; POSTOPERATIVE CARE; PRACTICE GUIDELINE; PREVALENCE; PULMONARY HYPERTENSION; QUALITY OF LIFE; SAUDI ARABIA; THROMBOSIS; THROMBOSIS PREVENTION; TREATMENT INDICATION; DOPPLER ECHOCARDIOGRAPHY; HEART SEPTUM DEFECT; HEMODYNAMICS; LUNG ARTERY PRESSURE; NUCLEAR MAGNETIC RESONANCE IMAGING; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SAUDI;

EID: 84902489683     PISSN: 18171737     EISSN: 19983557     Source Type: Journal    
DOI: 10.4103/1817-1737.134015     Document Type: Article

References (27)

1. Engelfriet PM, Duffels MG, Möller T, Boersma E, Tijssen JG, Thaulow E, et al. Pulmonary arterial hypertension in adults born with a heart septal defect: The Euro Heart Survey on adult congenital heart disease. Heart 2007;93:682-7.
2. Nakahata Y, Hiraishi S, Oowada N, Ando H, Kimura S, Furukawa S, et al. Quantitative assessment of pulmonary vascular resistance and reactivity in children with pulmonary hypertension due to congenital heart disease using a noninvasive method: New Doppler-derived indexes. Pediatr Cardiol 2009;30:232-9.
3. Lopes AA, O'Leary PW. Measurement, interpretation and use of haemodynamic parameters in pulmonary hypertension associated with congenital cardiac disease. Cardiol Young 2009;19:431-5.
4. Giglia TM, Humpl T. Preoperative pulmonary hemodynamics and assessment of operability: Is there a pulmonary vascular resistance that precludes cardiac operation? Pediatr Crit Care Med 2010;11:S57-69.
5. Berger RM. Possibilities and impossibilities in the evaluation of pulmonary vascular disease in congenital heart defects. Eur Heart J 2000;21:17-27.
6. Wilkinson JL. Haemodynamic calculations in the catheter laboratory. Heart 2001;85:113-20.
7. Lopes AA, Dos Anjos Miranda R, Gonçalves RC, Thomaz AM. A computer-based matrix for rapid calculation of pulmonary hemodynamic parameters in congenital heart disease. Ann Thorac Med 2009;4:124-7.
8. Idrees MM, Al-Hajjaj M, Khan J, Al-Hazmi M, Alanezi M, Saleemi S, et al. Saudi guidelines on diagnosis and treatment of pulmonary arterial hypertension. Ann Thorac Med 2008;3:1-57.
9. Gatzoulis MA, Alonso-Gonzalez R, Beghetti M. Pulmonary arterial hypertension in paediatric and adult patients with congenital heart disease. Eur Respir Rev 2009;18:154-61.
10. Balzer DT, Kort HW, Day RW, Corneli HM, Kovalchin JP, Cannon BC, et al. Inhaled nitric oxide as a preoperative test (INOP Test I): The INOP Test Study Group. Circulation 2002;106:I76-81.
11. Feinstein JA. Evaluation, risk stratifi cation, and management of pulmonary hypertension in patients with congenital heart disease. Semin Thorac Cardiovasc Surg Pediatr Card Surg Annu 2009;12:106-11.
12. Attie F, Rosas M, Granados N, Zabal C, Buendía A, Calderón J. Surgical treatment for secundum atrial septal defects in patients >40 years old. A randomized clinical trial. J Am Coll Cardiol 2001;38:2035-42.
13. Lindberg L, Olsson AK, Jögi P, Jonmarker C. How common is severe pulmonary hypertension after pediatric cardiac surgery? J Thorac Cardiovasc Surg 2002;123:1155-63.
14. Adatia I, Beghetti M. Immediate postoperative care in pulmonary hypertension associated with congenital heart disease. Cardiol Young 2009;19 E-Suppl 1:23-7.
15. Miller OI, Tang SF, Keech A, Pigott NB, Beller E, Celermajer DS. Inhaled nitric oxide and prevention of pulmonary hypertension after congenital heart surgery: A randomised double-blind study. Lancet 2000;356:1464-9.
16. Namachivayam P, Theilen U, Butt WW, Cooper SM, Penny DJ, Shekerdemian LS. Sildenafil prevents rebound pulmonary hypertension after withdrawal of nitric oxide in children. Am J Respir Crit Care Med 2006;174:1042-7.
17. Bush A, Busst CM, Haworth SG, Hislop AA, Knight WB, Corrin B, et al. Correlations of lung morphology, pulmonary vascular resistance, and outcome in children with congenital heart disease. Br Heart J 1988;59:480-5.
18. Kannan BR, Sivasankaran S, Tharakan JA, Titus T, Ajith Kumar VK, Francis B, et al. Long-term outcome of patients operated for large ventricular septal defects with increased pulmonary vascular resistance. Indian Heart J 2003;55:161-6.
19. Dimopoulos K, Giannakoulas G, Wort SJ, Gatzoulis MA. Pulmonary arterial hypertension in adults with congenital heart disease: Distinct differences from other causes of pulmonary arterial hypertension and management implications. Curr Opin Cardiol 2008;23:545-54.
20. Dimopoulos K, Peset A, Gatzoulis MA. Evaluating operability in adults with congenital heart disease and the role of pretreatment with targeted pulmonary arterial hypertension therapy. Int J Cardiol 2008;129:163-71.
21. Lopes AA. Pre-operative pulmonary hypertension in congenital heart disease, and aspects of the Eisenmenger syndrome. In: Beghetti M, Barst R, Humpl T, Berger R, Ivy D, Schulze-Neick I, editors. Pediatric Pulmonary Hypertension. Munich: Elsevier Urban & Fischer; 2011. In press.
22. Diller GP, Gatzoulis MA. Pulmonary vascular disease in adults with congenital heart disease. Circulation 2007;115:1039-50.
23. Vongpatanasin W, Brickner ME, Hillis LD, Lange RA. The Eisenmenger syndrome in adults. Ann Intern Med 1998; 128:745-55.
24. Kidd L, Driscoll DJ, Gersony WM, Hayes CJ, Keane JF, O'Fallon WM, et al. Second natural history study of congenital heart defects. Results of treatment of patients with ventricular septal defects. Circulation 1993;87:I38-51.
25. Oya H, Nagaya N, Uematsu M, Satoh T, Sakamaki F, Kyotani S, et al. Poor prognosis and related factors in adults with Eisenmenger syndrome. Am Heart J 2002;143:739-44.
26. Galiè N, Beghetti M, Gatzoulis MA, Granton J, Berger RM, Lauer A, et al. Bosentan therapy in patients with Eisenmenger syndrome: A multicenter, double-blind, randomized, placebo-controlled study. Circulation 2006;114:48-54.
27. Dimopoulos K, Inuzuka R, Goletto S, Giannakoulas G, Swan L, Wort SJ, et al. Improved survival among patients with Eisenmenger syndrome receiving advanced therapy for pulmonary arterial hypertension. Circulation 2010;121:20-5.